Advisors Preferred’s BeOne Medicines Ltd ONC Stock Holding History

Advisors Preferred’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$112K	Buy	+312	New	+$107K	0.01%	201
2025 Q2	–	Sell	-534	Closed	-$145K	–	308
2025 Q1	$145K	Buy	+534	New	+$125K	0.02%	209
2018 Q1	–	Sell	-961	Closed	-$94K	–	305
2017 Q4	$94K	Buy	+961	New	+$88K	0.04%	138

Other funds holding ONC

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $73.6B AUM 18.65% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Capital International Inc Los Angeles, California $13.9B AUM 25.98% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Advisors Preferred's ONC Position: Q3 2026 in Review

Advisors Preferred opened a new position in BeOne Medicines Ltd (ONC) in Q3 2026: 312 shares worth $112K. The stake represents 0.01% of the portfolio and ranks #201 among its holdings. This is a return to the name: Advisors Preferred previously reported a position in ONC as recently as Q1 2025.

Advisors Preferred first reported a position in ONC in Q4 2017 and has held it in 3 quarters since. The position peaked at $145K in Q1 2025. 234 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

Advisors Preferred held 312 shares of BeOne Medicines Ltd worth $112K as of Q3 2026.
BeOne Medicines Ltd was a new Advisors Preferred position in Q3 2026.
BeOne Medicines Ltd made up 0.01% of Advisors Preferred's portfolio in Q3 2026, its #201 holding.
Advisors Preferred first reported a position in BeOne Medicines Ltd in Q4 2017 and has held it in 3 quarters since.
Advisors Preferred's BeOne Medicines Ltd position peaked at $145K in Q1 2025.
234 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Advisors Preferred's 13F filing for Q3 2026, filed 9 Nov 2026.